Dtsch Med Wochenschr 2013; 138(49): 2512-2514
DOI: 10.1055/s-0033-1349673
Geriatrie | Commentary
Geriatrie, Diabetologie
© Georg Thieme Verlag KG Stuttgart · New York

Diabetes mellitus und Demenz: neue Daten

New data on diabetes and dementia
D. Kopf
1   Klinik für Geriatrie und Zentrum für klinische Psychologie und Psychotherapie, Katholisches Marienkrankenhaus Hamburg
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
26. November 2013 (online)

    Lizenzen und Reprints

Schlüsselwörter

Diabetes mellitus - Demenz

Keywords

diabetes mellitus - dementia
 

  • Literatur

  • 1 Allen VJ, Methven L, Gosney MA. Use of nutritional complete supplements in older adults with dementia: systematic review and meta-analysis of clinical outcomes. Clin Nutr 2013; Mar 28 [Epub ahead of print]
    Google Scholar
  • 2 Buchman AS, Boyle PA, Yu L et al. Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology 2012; 78: 1323-1329
    CrossrefGoogle Scholar
  • 3 Bomfim TR, Forny-Germano L, Sathler LB et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated Aβ oligomers. J Clin Invest 2012; 122: 1339-1353
    CrossrefGoogle Scholar
  • 4 Craft S, Baker LD, Montine TJ et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol 2012; 69: 29-38
    CrossrefGoogle Scholar
  • 5 Crane PK, Walker R, Hubbard RA et al. Glucose levels and risk of dementia. N Engl J Med 2013; 369: 540-548
    CrossrefGoogle Scholar
  • 6 Feinkohl I, Aung PP, Keller M et al. Edinburgh Type 2 Diabetes Study (ET2DS) Investigators. Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 2013; Oct 8. [Epub ahead of print]
    Google Scholar
  • 7 Fitzpatrick AL, Kuller LH, Lopez OL et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol 2009; 66: 336-342
    CrossrefGoogle Scholar
  • 8 Kopf D, Frölich L. Risk of incident Alzheimer's disease in diabetic patients: a systematic review of prospective trials. J Alzheimers Dis 2009; 16: 677-685
    Google Scholar
  • 9 Launer LJ, Miller ME, Williamson JD et al. ACCORD MIND investigators. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol 2011; 10: 969-977
    CrossrefGoogle Scholar
  • 10 Pandini G, Pace V, Copani A et al. Insulin has multiple antiamyloidogenic effects on human neuronal cells. Endocrinology 2013; 154: 375-387
    CrossrefGoogle Scholar
  • 11 Ravona-Springer R, Schnaider-Beeri M, Goldbourt U. Body weight variability in midlife and risk for dementia in old age. Neurology 2013; 80: 1677-1683
    CrossrefGoogle Scholar
  • 12 Scheltens P, Twisk JW, Blesa R et al. Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. J Alzheimers Dis 2012; 31: 225-236
    Google Scholar
  • 13 Stange I, Bartram M, Liao Y et al. Effects of a low-volume, nutrient- and energy-dense oral nutritional supplement on nutritional and functional status: a randomized, controlled trial in nursing home residents. J Am Med Dir Assoc 2013; 14: 628.e1-8
    Google Scholar
  • 14 Sullivan MD, Katon WJ, Lovato LC et al. Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND Trial. JAMA Psychiat 2013; 70 (10) 1041-1047
    Google Scholar
  • 15 Thambisetty M, Metter EJ, Yang A et al. Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging. JAMA Neurol 2013; 70 (09) 1167-1172
    CrossrefGoogle Scholar